Abiopharma

(80% Positive) MIDDLEBY CORP (MIDD) Reports Q2 2026 Financial Results

(99% Neutral) HEALTHPEAK PROPERTIES, INC. (DOC) Announces Regulatory Update

APARADISE ACQUISITION CORP. (APADU) Files Form 10-Q

BRAZIL POTASH CORP. (GRO) Files Form 6-K

(99% Neutral) JFB CONSTRUCTION HOLDINGS (JFB) Announces Executive Changes

(99% Neutral) NBT BANCORP INC (NBTB) Announces Regulatory Update

(99% Neutral) BLOCK, INC. (XYZ) Announces New Board Appointment

Agenus Inc. - Agenus to Provide First Quarter 2026 Financial Report and Corporate Update

(99% Neutral) MARKER THERAPEUTICS, INC. (MRKR) Announces Regulatory Update

(99% Positive) HUBBELL INC (HUBB) Announces Business Combination

(99% Neutral) MESABI TRUST (MSB) Reports Q2 2026 Financial Results

(99% Neutral) GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP. (GCGRU) Announces Business Combination

(99% Neutral) VIRGINIA NATIONAL BANKSHARES CORP (VABK) Announces Update on Collaboration with VIRGINIA NATIONAL BANKSHARES CORPORATION

(99% Neutral) ALLIED GAMING & ENTERTAINMENT INC. (AGAE) Announces Business Combination

Kenneweg John 🟡 adjusted position in 7.8K shares (1 derivative) of 908 Devices Inc. (MASS) at $6.83 Transaction Date: May 01, 2026 | Filing ID: 000007